Skip to content

Clinical efficacy analysis of repetitive transcranial magnetic stimulation in patients with vestibular syndrome

Clinical efficacy analysis of repetitive transcranial magnetic stimulation in patients with vestibular syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093690
Enrollment
Unknown
Registered
2024-12-10
Start date
2024-03-06
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic vestibular syndrome

Interventions

rTMS group:The rTMS coil stimulates the motor cortex of the brain to determine the optimal location where motor evoked potentials can be evoked, moving 5 cm forward parallel as the location of the DLP
sham-rTMS group :The rTMS coil stimulates the motor cortex of the brain to determine the optimal location where motor evoked potentials can be evoked, moving 5 cm forward parallel as the location of t

Sponsors

the Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the PPPD diagnostic criteria established by Barany Association; 2. Have not received rTMS treatment; 3. No serotonin reuptake inhibitors (SSRI) or serotonin norepinephrine reuptake inhibitors (SNRIs) were taken in the 3 weeks prior to the study; 4. Vestibular function examination showed no obvious abnormality; 5. Right-handed patients.

Exclusion criteria

Exclusion criteria: 1. Central dizziness caused by trauma, surgery, tumor, encephalitis, cerebrovascular malformations and other neurological diseases of the brain; 2. Contraindications of rTMS include metal foreign bodies in the skull, cardiac pacemakers, cochlear implants, increased intracranial pressure after brain injury, signs of brain abnormalities, epilepsy, etc. 3. Accompanied by clinically relevant mental disorders, medical and neurological diseases; 4. Alcohol or drug abuse; 5. History of head trauma with loss of consciousness and pregnancy; 6. Participating in other scientific research projects.

Design outcomes

Primary

MeasureTime frame
Dizziness handicap inventory,DHI;Visual aanalogue scale;Vestibular activities and participation,VAP;

Secondary

MeasureTime frame
Hamilton anxiety scale;Hamilton depression scale;Pittsburgh Sleep Quality Index;

Countries

China

Contacts

Public ContactYangmei Chen

the Second Affiliated Hospital of Chongqing Medical University

chenym1997@cqmu.edu.cn+86 136 0834 8562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026